Stroke Trial, Recruiting NCT07614074 Sponsor: University of California, San Francisco Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07614074
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older at the time of hospital admission
  • People who have been in a coma for at least 24 hours after arriving at the hospital, or who passed away before the 24-hour mark without regaining consciousness. A coma here means a very low level of consciousness based on a standard medical scale — not being able to follow commands, having very limited verbal response, and where the reduced consciousness is not explained only by sedating medications
  • People whose coma was caused by a brain or nervous system problem, such as a head injury, stroke, lack of oxygen to the brain, a brain infection, seizures, or similar conditions
  • People who were admitted to an intensive care unit (ICU), or who passed away before reaching the ICU

Who may not be able to join:

  • People who already had a very low level of consciousness or severe neurological impairment before this hospital admission, based on a specific score on a standard medical scale
  • People transferred from another hospital where records of their level of consciousness on the day after first arriving at hospital are not available and cannot be worked out from medical history or records
  • People whose coma was caused by a serious body-wide infection (sepsis), organ failure, or the effects of sedating medications
  • People whose inability to follow commands appears to be caused by a specific type of language difficulty (called receptive aphasia) resulting from a focused area of brain damage, rather than a true coma (confirm with trial site)
  • People who are currently imprisoned

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Claude Hemphill, MD, MAS, University of California, San Francisco

Phone: 415-476-5100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 September 2023
Est. completion
1 September 2033

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Modified Rankin Scale (mRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov